BNTC
Price
$12.68
Change
+$0.24 (+1.93%)
Updated
Sep 4 closing price
Capitalization
435.61M
Intraday BUY SELL Signals
MENS
Price
$2.39
Change
+$0.12 (+5.29%)
Updated
Sep 4 closing price
Capitalization
177.42M
Intraday BUY SELL Signals
Interact to see
Advertisement

BNTC vs MENS

BNTC vs MENS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BNTC vs. MENS commentary
Sep 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTC is a Hold and MENS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2026
Stock price -- (BNTC: $12.68 vs. MENS: $2.39)
Brand notoriety: BNTC and MENS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTC: 31% vs. MENS: 115%
Market capitalization -- BNTC: $435.61M vs. MENS: $177.42M
BNTC [@Biotechnology] is valued at $435.61M. MENS’s [@Biotechnology] market capitalization is $177.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTC’s FA Score shows that 0 FA rating(s) are green whileMENS’s FA Score has 1 green FA rating(s).

  • BNTC’s FA Score: 0 green, 5 red.
  • MENS’s FA Score: 1 green, 4 red.
According to our system of comparison, MENS is a better buy in the long-term than BNTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTC’s TA Score shows that 5 TA indicator(s) are bullish while MENS’s TA Score has 5 bullish TA indicator(s).

  • BNTC’s TA Score: 5 bullish, 6 bearish.
  • MENS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MENS is a better buy in the short-term than BNTC.

Price Growth

BNTC (@Biotechnology) experienced а +1.68% price change this week, while MENS (@Biotechnology) price change was +0.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.22%. For the same industry, the average monthly price growth was +5.23%, and the average quarterly price growth was +2396.59%.

Industries' Descriptions

@Biotechnology (-0.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTC($436M) has a higher market cap than MENS($177M). BNTC YTD gains are higher at: -5.865 vs. MENS (-42.532).
BNTCMENSBNTC / MENS
Capitalization436M177M246%
EBITDA-46.12MN/A-
Gain YTD-5.865-42.53214%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash185MN/A-
Total Debt876KN/A-
FUNDAMENTALS RATINGS
BNTC: Fundamental Ratings
BNTC
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNTCMENS
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 8 days ago
90%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BNTC
Daily Signal:
Gain/Loss:
MENS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OIGCX22.23N/A
N/A
Invesco International Growth C
CFLGX27.25N/A
N/A
ClearBridge Tactical Dividend Income A
LVOAX19.97N/A
N/A
Lord Abbett Value Opportunities A
NIAGX15.37N/A
N/A
Nia Impact Solutions
AGVFX31.30-0.02
-0.06%
American Funds Global Insight A